Active Ingredient
Tolnaftate 1%
The following Structured Product Label (SPL) was submitted to the FDA by Taisho Pharmaceutical California Inc. for the product Derman Antifungal Powder Tolnaftate (NDC 81929-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Tolnaftate 1%
Antifungal
Proven clinically effective in the treatment of most:
Clinically proven to prevent most athlete's foot with daily use Relieves
For external use only
Flammable: Contents under pressure. Do not puncture or incinetare or store at a temperature above 120°F. Use only as directed. Intentional misuse by deliberately concentrating and inhaling aerosol products can be harmful or fatal. Do not use near flame or spark or white smoking.
on children under 2 years of age unless directed by a doctor.
avoid contact with the eyes
if irritation occurs or if there is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch)
If swallowed, get medical help or contact a Poison Control Center right away
store between 20° and 30°C (68° and 86°F)
BHT, Corn Starch, Isobutane, Kaolin, PPG-12-Buteth-16, SD Alcohol 40-B
* Please review the disclaimer below.